MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Oxazyme in Patients With Hyperoxaluria
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2012-12-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 22
- Registration Number
- NCT01127087
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Behavior Therapy Prior to Bariatric Surgery
Phase 1
Completed
- Conditions
- Obesity
- Interventions
- Behavioral: LEARN group
- First Posted Date
- 2010-05-18
- Last Posted Date
- 2013-05-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 34
- Registration Number
- NCT01125397
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Vagal Nerve Stimulation and Glucose Metabolism
Not Applicable
Completed
- Conditions
- Type 2 DiabetesObesityGastric Emptying
- Interventions
- Device: VNB onDevice: VNB off
- First Posted Date
- 2010-05-05
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 9
- Registration Number
- NCT01117311
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Neuromodulation Therapy Device for the Treatment of Sleep Apnea
Phase 1
Completed
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Device: Neuromodulation Therapy Device (NMTD)
- First Posted Date
- 2010-05-05
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 18
- Registration Number
- NCT01117064
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression
Not Applicable
Terminated
- Conditions
- Depression
- Interventions
- Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 2
- Registration Number
- NCT01115699
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Finger Hardness Measure in Scleroderma
Completed
- Conditions
- Scleroderma
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT01111786
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 2
- Registration Number
- NCT01106027
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Tobacco Cessation Treatment for Alaska Native Youth
Phase 1
Completed
- Conditions
- Tobacco Cessation
- Interventions
- Behavioral: Written self-help materialsBehavioral: Group behavioral counseling
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT01099384
- Locations
- 🇺🇸
Yukon Kuskokwim Health Corporation, Bethel, Alaska, United States
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2013-01-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4900
- Registration Number
- NCT01098552
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation
- First Posted Date
- 2010-03-30
- Last Posted Date
- 2015-07-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT01095887
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath